“The new LightCycler® Nano Instrument delivers proven high quality at an affordable price & expands our qPCR business into a new segment. Customers will love the smart design of the instrument & appreciate the high quality data they can produce with it.”
Gerd Haberhausen, Roche
“With the LightCycler® Nano Instrument, we now provide a very compact & innovative high performance PCR instrument under a worldwide exclusive agreement”
Gerd Haberhausen, Roche
"end of Roche global service and support for the LightCycler® Nano Instrument is 31 December 2020"
Some say there's no demand for instrument to test between 4 & 96 samples
Some people have been wrong quite a bit recently, even been caught out lying. I'll trust the words of Roche's Vice President of Marketing, love those Marketing savyy folks lse.co.uk/ShareChat.asp?…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
👇 Wrong:
"So in essence if you look you will not find a document (that I have ever seen) saying Exsig formally passed its in service trial in relation to the contract whereas you will find one for Promate"
For supposed researched person, he's lazy. His thesis called out #Novacyt's 3rd party manufacturing for lowering margins
#ALNOV "invests in infrastructure to bring previously outsourced work in-house & to drive further automation, leading to improved margins & process controls"
#Mirriad "partnership comes at a time when consumers increasingly avoid ads & are becoming incredibly hard to reach & connect with. Brands need to become a deeply engaging part of peoples' experiences in new & radical ways"